Exenatide: a GLP-1 receptor agonist as novel therapy for type 2 diabetes mellitus
Most patients who have type II diabetes or prediabetes will get coverage from their health insurance plans
They will not replace counseling or peer support, but they might quiet the brain chatter that says just one more. Until the FDA stamps an addiction indication, discuss risks, costs, and realistic expectations with a clinician who knows both metabolic and mental-health terrain
As a response, GLP-1 drugs such as semaglutide (Ozempic and Wegovy) and dulaglutide (Trulicity) have The new study found that the L
More than 60% of GLP-1 RA users consumed below estimated requirements for calcium and iron, and vitamin D intake averaged just 20% of recommended intake ( Clin Obes , 2026)
Very pleased gave me energy and cleared up my skin